During the past decade, Vivantes Klinikum Spandau conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vivantes Klinikum Spandau" #1 sponsor was "Aesculap AG" with 1 trials, followed by "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored, "GWT-TUD GmbH" with 1 trials sponsored, "Hadassah Medical Organization" with 1 trials sponsored and "Hannover Medical School" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vivantes Klinikum Spandau" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials as a collaborator, "B.Braun Surgical SA" with 1 trials as a collaborator, "CAPNETZ Stiftung" with 1 trials as a collaborator and "ClinAssess GmbH" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Vivantes Klinikum Spandau" are "Non-Small Cell Lung Cancer" (2 trials), "Acute Myeloid Leukemia (AML)" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Basal Cell Carcinoma" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Vivantes Klinikum Spandau" in a lesser frequency.

Most popular intervention types in "Vivantes Klinikum Spandau" are "Drug" (10 trials), "Device" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Carboplatin" (2 trials), "Dexamethasone" (2 trials), "Paclitaxel" (2 trials) and "ABSORB Scaffold" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vivantes Klinikum Spandau" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Vivantes Klinikum Spandau". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Vivantes Klinikum Spandau, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Vivantes Klinikum Spandau, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".